Keyphrases
Insulin Sensitivity
100%
Brown Fat
100%
LDL Cholesterol
100%
Mirabegron
100%
Brown Adipose Tissue
60%
Metabolic Activity
60%
Adrenergic Receptor Agonists
60%
White Adipose Tissue
40%
Resting Energy Expenditure
40%
Adiponectin
20%
Whole-body
20%
Glucose-insulin System
20%
Body Composition
20%
Lipoproteins
20%
Insulin Secretion
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Apolipoprotein A-I (ApoA-I)
20%
Glucose Metabolism
20%
Plasma Glucose
20%
2-Deoxy-d-glucose (2-DG)
20%
Antidiabetic
20%
Changes in Body Weight
20%
Plasma Parameters
20%
Overactive Bladder Symptom Score (OABSS)
20%
Acute Treatment
20%
Adipokinetic Hormone
20%
Metabolic Disease
20%
Fluoro
20%
Pharma
20%
Glucose Effectiveness
20%
Intravenous Glucose Tolerance Test
20%
Insulin Metabolism
20%
Frequently Sampled Intravenous Glucose Tolerance Test
20%
Healthy Women
20%
Plasma Metabolites
20%
Adipocyte Lipolysis
20%
High Insulin
20%
Astellas
20%
Brown Adipose Tissue Thermogenesis
20%
Total Bile Acid
20%
Obesity-related Metabolic Diseases
20%
Pharmacological Stimulation
20%
Extended-release Tablets
20%
Biochemistry, Genetics and Molecular Biology
Insulin Sensitivity
100%
HDL-Cholesterol
100%
Receptor Agonists
100%
Adrenergic Receptor
100%
Metabolic Disorder
66%
Glucose Test
66%
Glucose Tolerance Test
66%
Resting Energy Expenditure
66%
Body Composition
33%
Lipoprotein
33%
Metabolite
33%
Blood Level
33%
Positron Emission Tomography-Computed Tomography
33%
Glucose Metabolism
33%
Insulin Release
33%
Body Weight
33%
Lipolysis
33%
Bile Acid
33%
Insulin Metabolism
33%
Thermogenesis
33%
Pharmacological Stimulation
33%
Blood Plasma
33%
Adiponectin
33%
2-Deoxy-D-Glucose
33%
Medicine and Dentistry
High Density Lipoprotein Cholesterol
100%
Insulin Sensitivity
100%
Brown Adipose Tissue
100%
Mirabegron
100%
Sympathomimetic Drug
50%
White Adipose Tissue
33%
Water-Electrolyte Imbalance
33%
Intravenous Glucose Tolerance Test
33%
Resting Energy Expenditure
33%
Biological Marker
16%
Adiponectin
16%
Positron Emission Tomography-Computed Tomography
16%
Body Mass Index
16%
Lipoprotein
16%
Insulin Release
16%
Glucose Metabolism
16%
Metabolite
16%
Overactive Bladder
16%
Bile Acid
16%
Fluorine-18
16%
Body Weight
16%
Deoxyglucose
16%
Lipolysis
16%
Insulin Metabolism
16%
Thermogenesis
16%
Pharmacological Stimulation
16%
Immunology and Microbiology
Brown Adipose Tissue
100%
Insulin Sensitivity
100%
Agonist
60%
White Adipose Tissue
40%
Resting Energy Expenditure
40%
Adiponectin
20%
Body Weight
20%
Blood Plasma
20%
Lipolysis
20%
Positron Emission Tomography-Computed Tomography
20%
Blood Level
20%
Glucose Metabolism
20%
Insulin Release
20%
Body Composition
20%
Metabolite
20%
Thermogenesis
20%
Insulin Metabolism
20%
Pharmacological Stimulation
20%
Lipoprotein
20%
Pharmacology, Toxicology and Pharmaceutical Science
High Density Lipoprotein Cholesterol
100%
Mirabegron
100%
Adrenergic Receptor Stimulating Agent
50%
Metabolic Disorder
33%
Biological Marker
16%
Lipoprotein
16%
Deoxyglucose
16%
Adiponectin
16%
Bile Acid
16%
Fluorine 18
16%
Overactive Bladder
16%
Tablet
16%
Pharmacological Stimulation
16%
Polyethylene Terephthalate
16%